The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Jul 2022 07:00

RNS Number : 9178R
Norman Broadbent PLC
11 July 2022
 

Norman Broadbent plc

("Norman Broadbent", the "Company" or the "Group")

Trading Update

Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, is pleased to provide the following trading update for the 6 months ended 30 June 2022 ("H1 2022").

Financial highlights

Net Fee Income

H1 2022

H1 2021

% Change

£'000

£'000

Executive Search

2,581

1,995

29%

Interim Management

715

752

-

---------

---------

Group Total

3,296

2,747

20%

 

· Following on from a strong Q4 2021, net fee income ("NFI") in H1 2022 increased by 20% to £3.3m (H1 2021: £2.7m) driven by growth in Executive Search NFI.

· Executive Search NFI grown by 29% to £2.6m (H1 2021: £2.0m) through culture change, increased focus on senior mandates and improved brand positioning across core sectors.

· Interim Management NFI slightly down year on year ("YOY") at £0.7m, however, an operational focus to grow the Company's book of long-term contractors versus purely fixed term contracts has seen a considerable increase in contractor numbers and recurring income from these long term contractors, providing additional H2 2022 NFI visibility of £0.2m.

· Average new search fee value increased by 30% YOY.

· Average NFI per fee earner up 40% YOY.

· 50% growth in number of fee earners since start of 2022.

· Days Sales Outstanding (DSO) reduced to 45 days as of 30 June 2022 (versus 66 days year-end 2021).

· New office openings scheduled in Scotland for H2 2022 to leverage industrial, financial services, retail / consumer, digital / technology and interim management practices across the UK. Experienced executive search leaders already recruited in Scotland to drive this market expansion.

· EBITDA for H1 2022 is expected to be in the range £40k to £60k, making progress to pre-covid earnings, but on a reshaped business built for growth. The Group will publish its unaudited interim results for the half year ended 30 June 2022 in mid-August 2022.

Kevin Davidson, Group CEO of Norman Broadbent plc, said:

 

"We are delighted with the progress the entire business has made and that this is quickly translating into improved financial performance whilst we continue to invest heavily in growth and business transformation. 

It is encouraging to see that our immediate focus on re-establishing Norman Broadbent's position at the forefront of executive and board search, along with rebuilding the interim runner book, are both bearing fruit. We have grown our team across multiple core sectors over the past 9 months, especially industrial, digital / technology and retail / consumer. Our Research and Insights team has also continued to expand, and all new appointments have established themselves quickly, adding to the evolving culture of the business and its future prospects.

With continued headcount growth, new office openings scheduled for H2 and a continued focus on higher value search and long-term recurring interim contractor income, I am confident in the trajectory the business is now on. There will clearly be some macro-economic headwinds in the coming months but with a relentless focus on quality, client satisfaction and culture we believe we can continue to build the business whilst generating sustainable profits in the years ahead."

 For further information, please contact:

Norman Broadbent plc

Kevin Davidson / Peter Searle / Steve Smith

 

020 7484 0000

WH Ireland LimitedJessica Cave / Darshan Patel

020 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQVLFBLDLZBBX
Date   Source Headline
20th May 20225:49 pmRNSIssue of Convertible Loan Notes
11th May 20224:16 pmRNSDirector resignation
18th Mar 20227:00 amRNSGrant of Options to Directors and Employees
2nd Mar 20227:00 amRNSFY2021 Trading Update
7th Feb 20227:00 amRNSBoard Changes
7th Dec 20213:50 pmRNSHolding(s) in Company
6th Dec 202110:18 amRNSSubscription
2nd Dec 20217:00 amRNSHolding(s) in Company
12th Nov 20212:30 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSAppointment of Group Managing Director
27th Sep 20217:02 amRNSSubscription Results and PDMR Dealing
27th Sep 20217:00 amRNSInterim Results for Six Months Ended 30 June 2021
12th Aug 20217:00 amRNSBoard Changes
12th Jul 20217:00 amRNSBoard Changes
25th Jun 202112:30 pmRNSResult of AGM
15th Jun 20217:00 amRNSAppointment of Executive Chairman
24th May 20217:00 amRNSFinal Results and Annual Accounts
13th May 202111:59 amRNSHolding(s) in Company
12th May 202112:17 pmRNSHolding(s) in Company
12th May 20219:39 amRNSHolding(s) in Company
19th Apr 202111:59 amRNSNotice of Results
19th Apr 202111:53 amRNSHolding(s) in Company
25th Jan 20217:00 amRNSFY2020 Trading Update
26th Nov 20207:00 amRNSFunding Update
23rd Nov 20204:54 pmRNSHolding(s) in Company
21st Oct 20201:45 pmRNSAppointments - Group Managing Director & Others
16th Oct 20201:00 pmRNSDirector/PDMR Shareholding & Concert Party Update
5th Oct 20203:01 pmRNSIssue of Equity
5th Oct 20207:00 amRNSAcquisition of minority interest in NBIMv
28th Sep 20207:00 amRNSInterim Results
27th Aug 202010:40 amRNSDirectorate Change
24th Aug 202010:59 amRNSDirector/PDMR Shareholding
28th Jul 202010:18 amRNSResult of AGM and Appointment of Chair
28th Jul 20207:00 amRNSAGM Statement and Trading Update
16th Jul 202010:35 amRNSHolding(s) in Company
29th Jun 20207:00 amRNSFinal Results and Annual Accounts
26th May 202011:32 amRNSDirector/PDMR Shareholding
18th May 202012:33 pmRNSDirector/PDMR Shareholding
18th May 20207:00 amRNSTrading Update
11th Mar 202012:00 pmRNSAppointment of CFO & COO
9th Mar 20207:00 amRNSChange of address
3rd Mar 20207:00 amRNSExpansion driven by increased client demand
28th Feb 20207:00 amRNSUpdate: Chief Financial Officer Succession
24th Jan 20207:00 amRNSTrading Update
10th Dec 20197:00 amRNSNorman Broadbent Group partners with UN Women UK
26th Sep 20197:00 amRNSInterim Results for six months ended 30 June 2019
9th Sep 20197:00 amRNSNew and Enhanced Working Capital Facility
23rd Aug 201911:31 amRNSHolding(s) in Company
23rd Aug 201910:51 amRNSShareholder Update and Director/PDMR Shareholding
6th Aug 20194:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.